Pharmacodynamic, pharmacokinetic and physical characterization of cilnidipine loaded solid lipid nanoparticles for oral delivery optimized using the principles of design of experiments-Reference-Cited by-同舟云学术

Pharmacodynamic, pharmacokinetic and physical characterization of cilnidipine loaded solid lipid nanoparticles for oral delivery optimized using the principles of design of experiments

Published:2020-09 Issue: Volume:193 Page:111073
ISSN:0927-7765
Container-title:Colloids and Surfaces B: Biointerfaces
language:en
Short-container-title:Colloids and Surfaces B: Biointerfaces

Author:

Diwan Rimpy,Ravi Punna Rao,Pathare Nikita Shantaram,Aggarwal Vidushi

Funder

DST, New Delhi

Publisher

Elsevier BV

Subject

Colloid and Surface Chemistry,Physical and Theoretical Chemistry,Surfaces and Interfaces,General Medicine,Biotechnology

Reference33 articles.

1. Relationship between lipophilicities of 1, 4-dihydropyridine derivatives and pharmacokinetic interaction strengths with grapefruit juice;Uesawa;Yakugaku Zasshi,2008

2. Metabolism and metabolic inhibition of cilnidipine in human liver microsomes;Liu;Acta Pharmacol. Sin.,2003

3. Cilnidipine: next generation calcium channel blocker;Shete;J. Assoc. Physicians India,2016

4. Preparation and evaluation of cilnidipine microemulsion;Tandel;J. Pharm. Bioallied Sci.,2012

5. Preparation, characterization and tableting of cilnidipine solid dispersions;Hu;Pak. J. Pharm. Sci.,2013

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design of Optimized Solid Lipid Nanoparticles of Montelukast Sodium and Assessment of Oral Bioavailability in Experimental Model;Current Pharmaceutical Biotechnology;2024-06-24

2. Unveiling the pharmacological and nanotechnological aspects for the management of hypertension: State-of-the-art and future perspectives;Targeting Angiogenesis, Inflammation, and Oxidative Stress in Chronic Diseases;2024

3. Lipid nanoparticles in targeting Alzheimer's disease;Alzheimer's Disease and Advanced Drug Delivery Strategies;2024

4. Data-driven development of an oral lipid-based nanoparticle formulation of a hydrophobic drug;Drug Delivery and Translational Research;2023-12-29

5. Design of layer-by-layer lipid-polymer hybrid nanoparticles to elicit oral bioavailability of buspirone hydrochloride;International Journal of Polymeric Materials and Polymeric Biomaterials;2023-09-11